All JCVI articles
-
NewsPfizer and Vaxzevria COVID vaccines approved for use as boosters
MHRA approval will provide further options for the UK COVID-19 vaccination programme, should the JCVI recommend that booster doses be offered
-
News
JCVI updates guidance on COVID-19 vaccination for children and young people
The JCVI advises that certain at-risk groups of children and young people aged 12 years and over should be offered COVID-19 vaccination
-
News
JCVI issues autumn COVID-19 booster jab advice
UK vaccine adviser recommends a two-stage approach to coronavirus booster vaccine doses, beginning with those most at risk from serious disease
